Author
Listed:
- Zuqiang Liu
(University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center)
- Yan Ge
(University of Pittsburgh School of Medicine
Soochow University)
- Haiyan Wang
(University of Pittsburgh School of Medicine
Soochow University)
- Congrong Ma
(University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center)
- Mathilde Feist
(University of Pittsburgh School of Medicine
Charité—Universitaetsmedizin Berlin)
- Songguang Ju
(Soochow University)
- Z. Sheng Guo
(University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center)
- David L. Bartlett
(University of Pittsburgh School of Medicine
UPMC Hillman Cancer Center)
Abstract
The complex immune tumour microenvironment requires an equally complex immunotherapy approach, especially when the cancer-immune set point is non-inflamed. Oncolytic viruses expressing immune activating cytokines might optimally modify the immune microenvironment and improve the antitumour effects. In this study, we have explored a variety of IL-2 constructs expressed by a tumour-selective oncolytic vaccinia virus, designed to maintain IL-2 in the tumour microenvironment to reduce systemic toxicity. An IL-2 construct combining a glycosylphosphatidylinositol (GPI) anchor with a rigid peptide linker leads to functional IL-2 expression on the tumour cell surface and in the tumour microenvironment. This virus construct effectively modifies the cancer-immune set point and treats a variety of murine tumour models with no toxic side effects. In combination with PD-1/PD-L1 blockade this virus cures most of the mice with a high tumour burden. This combination represents a treatment for cancers which are to date unresponsive to immunotherapy.
Suggested Citation
Zuqiang Liu & Yan Ge & Haiyan Wang & Congrong Ma & Mathilde Feist & Songguang Ju & Z. Sheng Guo & David L. Bartlett, 2018.
"Modifying the cancer-immune set point using vaccinia virus expressing re-designed interleukin-2,"
Nature Communications, Nature, vol. 9(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06954-z
DOI: 10.1038/s41467-018-06954-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-06954-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.